AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas. Torka P, Russell T, Mavis C, Gu J, et al. Leuk Lymphoma 2023;64:1175-1185.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Torka P, Russell T, Mavis C, Gu J, et al. AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas. Leuk Lymphoma 2023;64:1175-1185.
PMID: 37074033